Published in J Hepatol on September 01, 2000
High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy. World J Gastroenterol (2005) 0.75
Nonresponse to interferon monotherapy in HCV-related chronic hepatitis: results of retreatment and prognostic factors. Dig Dis Sci (2003) 0.75
High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus. Dig Dis Sci (2001) 0.75
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut (2004) 3.26
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome. Acta Neurol Scand (2014) 2.59
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol (2001) 2.36
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2011) 2.34
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol (2011) 2.31
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology (2001) 1.99
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2011) 1.95
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther (2011) 1.73
The long-term course of chronic hepatitis B. Hepatology (1999) 1.63
Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis (2009) 1.58
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther (2011) 1.58
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology (1995) 1.57
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. J Viral Hepat (2013) 1.51
Life-threatening intracranial hypotension after diagnostic lumbar puncture. Neurol Sci (2001) 1.49
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology (1983) 1.49
Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol (1994) 1.44
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1994) 1.40
Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol (1991) 1.40
Spinal disorders at the cervicothoracic junction. Spine (Phila Pa 1976) (1994) 1.27
Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci (2010) 1.24
Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrhea. Arch Virol (1997) 1.23
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Hepatitis C virus and Sjögren's syndrome. Lancet (1992) 1.19
Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15
Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol (2012) 1.14
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Aliment Pharmacol Ther (2008) 1.12
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci (1983) 1.12
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
Delta agent and hepatocellular carcinoma. Prog Clin Biol Res (1983) 1.08
Long-term interferon-beta treatment for multiple sclerosis. Neurol Sci (2003) 1.06
Characterization of Sicilian strains of spotted fever group rickettsiae by using monoclonal antibodies. J Clin Microbiol (1989) 1.06
Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. J Clin Pharm Ther (2013) 1.06
Low lumbar burst fractures. Comparison among body cast, Harrington rod, Luque rod, and Steffee plate. Spine (Phila Pa 1976) (1991) 1.04
Familial incidence of twinning. Nature (1983) 1.03
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr Pharm Des (2010) 1.01
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. Gut (2001) 1.00
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2007) 0.99
Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (1995) 0.99
Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif (2011) 0.98
Neurologic deterioration after cervical spinal cord injury. J Spinal Disord (1998) 0.98
[Transurethral incision of the prostate]. Arch Ital Urol Androl (1997) 0.97
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurol Sci (2004) 0.96
Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat (2004) 0.96
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. Gut (1984) 0.95
A comparison of three screw types for unicortical fixation in the lateral mass of the cervical spine. Spine (Phila Pa 1976) (2001) 0.95
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol (1991) 0.95
Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology (1994) 0.94
Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94
Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis (2008) 0.93
Oral pathology in untreated coeliac [corrected] disease. Aliment Pharmacol Ther (2007) 0.93
Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood (1997) 0.92
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis. J Cancer Res Clin Oncol (2013) 0.92
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther (1998) 0.92
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat (2013) 0.91
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer (2007) 0.91
Migraine and obesity: metabolic parameters and response to a weight loss programme. Pediatr Obes (2014) 0.90
Glibenclamide-associated reversible cholestasis. Eur J Med (1992) 0.90
Ictal headache and visual sensitivity. Cephalalgia (2008) 0.90
Acute necrotizing encephalopathy: a relapsing case in a European adult. J Neurol Neurosurg Psychiatry (2007) 0.90
A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. Clin Exp Immunol (1991) 0.90
Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis. J Med Virol (1992) 0.89
Formulation of a novel synthetic medium for selectively culturing rat CNS neurons. Brain Res (1985) 0.89
Gross pathologic types of hepatocellular carcinoma in Italy. Oncology (1999) 0.89
Is autoimmune chronic active hepatitis a HCV-related disease? J Hepatol (1991) 0.89
Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors. Curr Pharm Des (2007) 0.89
Metastatic hepatocellular carcinoma of the parotid region without lung metastasis: a case report. Int J Oral Maxillofac Surg (2009) 0.89
Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1999) 0.89
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J Viral Hepat (2009) 0.88
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study. Am J Clin Oncol (2000) 0.88
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat (2001) 0.88
Twin resemblances in creativity and in esthetic and emotional expression. Acta Genet Med Gemellol (Roma) (1976) 0.87
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome. Eur J Neurol (2011) 0.87
Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk. Am J Epidemiol (1991) 0.87
Triiodothyronine-induced shortening of chromatin repeat length in neurons cultured in a chemically defined medium. J Neurochem (1987) 0.87
The impact of antiviral therapy on the course of chronic HCV infection. A systematic review. Panminerva Med (2003) 0.86
Effects of black widow spider venom on acetylcholine release from rat cerebral cortex slices in vitro. Biochem Pharmacol (1972) 0.86
Cognitive and linguistic abnormalities in benign childhood epilepsy with centrotemporal spikes. Acta Paediatr (2011) 0.86
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology (1999) 0.86
Antiepileptic drug withdrawal in childhood epilepsy: what are the risk factors associated with seizure relapse? Eur J Paediatr Neurol (2012) 0.86
Lip cancer: a 10-year retrospective epidemiological study. Anticancer Res (2012) 0.86